共 50 条
- [1] COX-2 inhibitors and cardiovascular risk [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
- [3] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors [J]. Arthritis Res Ther, 5
- [4] COX-2 inhibitors: cancer prevention or cardiovascular risk? [J]. LANCET ONCOLOGY, 2005, 6 (02): : 68 - 68
- [5] Risk of cardiovascular events associated with COX-2 inhibitors [J]. HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
- [8] Rofecoxib, selective COX-2 inhibitors and cardiovascular risk [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2005, 35 (02): : 101 - 103
- [9] Risk of cardiovascular events associated with selective COX-2 inhibitors [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
- [10] Cardiovascular safety of COX-2 inhibitors [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1118): : 99 - 100